ABAnass Benfares

Anass Benfares

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anass Benfares has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Interpretable Machine Learning Model for the Differentiation of Liver Cysts and Liver Tumors Based on Computed Tomography (CT) Imaging

    by Mamoun Qjidaa, Anass Benfares, Mohammed Amine El Azami El Hassani, Amine Benkabbou, Amine Souadka, Anass Majbar, Zakaria El Moatassim, Maroua Oumlaz, Oumayma Lahnaoui, Raouf Mouhcine, et al.

    Background: Metastatic liver tumors (MLT) and parasitic liver cysts (PLC) are common liver conditions that often exhibit similar imaging characteristics, making accurate diagnosis challenging using imaging alone. This overlap can result in diagnostic errors and delayed treatment, particularly in resource-limited settings or when invasive procedures such as biopsies are not feasible due to risk or unavailability. This study aimed to develop a reliable and transparent machine learning approach to distinguish MLT from PLC using radiomic features derived from computed tomography (CT). Methods: We propose an explainable radiomics-based machine learning framework for the non-invasive, accurate, and interpretable discrimination of MLT and PLC, designed to assist radiologists in reducing diagnostic ambiguity and expediting patient management. This retrospective study included 30 adult patients, comprising 15 with liver metastases and 15 with pathologic hepatic cysts. Radiomic features were extracted from pre-treatment CT scans using PyRadiomics. Feature selection was performed using three complementary methods: Mutual Information, Lasso regression, and LightGBM importance ranking. HistGradientBoosting classifiers were then trained on each selected feature set. Results: Model performance was evaluated using 5-fold cross-validation and assessed with ROC AUC, accuracy, precision, recall, and F1-score. SHAP analysis was applied to interpret the models and identify key radiomic biomarkers. Statistical comparisons were performed using DeLong’s test for AUCs, McNemar’s test for classification agreement, and paired t-tests for metrics such as accuracy and F1-score. The Mutual Information-based model achieved the highest mean AUC (0.9717 ± 0.0267), significantly outperforming the other models (p < 0.035). Key features contributing to classification included texture entropy, interquartile range, and gray level non-uniformity. Conclusion: We developed a robust and interpretable machine learning framework for differentiating metastatic liver tumors from parasitic liver cysts using CT-derived radiomic features. The integration of Mutual Information feature selection, ensemble learning, and SHAP explainability ensured high diagnostic accuracy, strong calibration, and transparency. The proposed framework demonstrates substantial clinical relevance and holds promise for real-world implementation.

  • Open Access

    Automated Differentiation of Hepatic Cysts and Metastatic Tumors Using a Deep Learning Ensemble Framework on CT Imaging in Low-Resource Areas

    by Mamoun Qjidaa, Amine Souadka, Anass Benfares, Mohammed Amine El Azami El Hassani, Amine Benkabbou, Anass Majbar, Zakaria El Moatassim, Maroua Oumlaz, Oumayma Lahnaoui, Raouf Mouhcine, et al.

    Background/Objectives: In resource-limited settings, where access to advanced imaging modalities such as magnetic resonance imaging (MRI) and histopathological confirmation may be limited, differentiating between hepatic cysts and metastatic lesions based solely on computed tomography (CT) remains challenging. This limitation may affect diagnostic confidence and increase the risk of misclassification, potentially impacting clinical decision making and patient management. In this study, we aimed to explore a more direct and automated approach for classifying hepatic lesions from CT images. Methods: We developed a deep learning-based framework combining transfer learning, decision fusion, and a stacking strategy by integrating five CNN architectures. The study included 100 patients, equally divided between metastatic liver tumors and pathological hepatic cysts. The dataset was built from both public data (LiTS) and internal clinical cases, and then split into training and testing sets. Results: The proposed stacking model provided the most consistent results, reaching an accuracy of 0.98, with high precision and sensitivity. The improvements in individual models, although moderate, were observed across all evaluation metrics. Conclusions: Overall, this approach offers a practical and reliable way to classify hepatic lesions with minimal manual intervention. It may help improve consistency in diagnosis and could be integrated into clinical workflows to support decision making in low-resource areas.

  • Open Access

    NSCLC EGFR Mutation Prediction via Random Forest Model: A Clinical–CT–Radiomics Integration Approach

    by Anass Benfares, Badreddine Alami, Sara Boukansa, Mamoun Qjidaa, Ikram Benomar, Mounia Serraj, Ahmed Lakhssassi, Mohammed Ouazzani Jamil, Mustapha Maaroufi, Hassan Qjidaa

    Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Accurate determination of epidermal growth factor receptor (EGFR) mutation status is essential for selecting patients eligible for tyrosine kinase inhibitors (TKIs). However, invasive genotyping is often limited by tissue accessibility and sample quality. This study presents a non-invasive machine learning model combining clinical data, CT morphological features, and radiomic descriptors to predict EGFR mutation status. A retrospective cohort of 138 patients with confirmed EGFR status and pre-treatment CT scans was analyzed. Radiomic features were extracted with PyRadiomics, and feature selection applied mutual information, Spearman correlation, and wrapper-based methods. Five Random Forest models were trained with different feature sets. The best-performing model, based on 11 selected variables, achieved an AUC of 0.91 (95% CI: 0.81–1.00) under stratified five-fold cross-validation, with an accuracy of 0.88 ± 0.03. Subgroup analysis showed that EGFR-WT had a performance of precision 0.93 ± 0.04, recall 0.92 ± 0.03, F1-score 0.91 ± 0.02, and EGFR-Mutant had a performance of precision 0.76 ± 0.05, recall 0.71 ± 0.05, F1-score 0.68 ± 0.04. SHapley Additive exPlanations (SHAP) analysis identified tobacco use, enhancement pattern, and gray-level-zone entropy as key predictors. Decision curve analysis confirmed clinical utility, supporting its role as a non-invasive tool for EGFR-screening.


  • Open Access

    High-Precision, Automatic, and Fast Segmentation Method of Hepatic Vessels and Liver Tumors from CT Images Using a Fusion Decision-Based Stacking Deep Learning Model

    by Mamoun Qjidaa, Anass Benfares, Mohammed Amine El Azami El Hassani, Amine Benkabbou, Amine Souadka, Anass Majbar, Zakaria El Moatassim, Maroua Oumlaz, Oumayma Lahnaoui, Raouf Mouhcine, et al.

    Background: To propose an automatic liver and hepatic vessel segmentation solution based on a stacking model and decision fusion. This model combines the decisions of multiple models to achieve increased accuracy. It exhibits improved robustness due to the reduction of individual errors. Flexibility is also a key asset, with combination methods such as majority voting or weighted averaging. The model enables managing the uncertainty associated with individual decisions to obtain a more reliable final decision. The combination of decisions improves the overall accuracy of the system. Methods: This research introduces a new deep learning-based architecture for automatically segmenting hepatic vessels and tumors from CT scans, utilizing stacking, decision fusion, and deep transfer learning to achieve high-accuracy and rapid segmentation. This study employed two distinct datasets: the external “Medical Segmentation Decathlon (MSD) task 08” dataset and an internal dataset procured from Ibn Sina University Hospital encompassing a cohort of 112 patients with chronic liver disease who underwent contrast-enhanced abdominal CT scans. Results: The proposed segmentation model reached a DSC of 83.21 and an IoU of 72.76 for hepatic vasculature and tumor segmentation, thereby exceeding the performance benchmarks established by the majority of antecedent studies. Conclusions: This study introduces an automated method for liver vessels and liver tumor segmentation, combining precision and stability to bridge the clinical gap. Furthermore, decision fusion-based stacking models have a significant impact on clinical applications by enhancing diagnostic accuracy, enabling personalized care through the integration of genetic, environmental, and clinical data, optimizing clinical trials, and facilitating the development of personalized medicines and therapies.


  • Open Access

    Nomogram Based on the Most Relevant Clinical, CT, and Radiomic Features, and a Machine Learning Model to Predict EGFR Mutation Status in Non-Small Cell Lung Cancer

    by Anass Benfares, Abdelali Yahya Mourabiti, Badreddine Alami, Sara Boukansa, Ikram Benomar, Nizar El Bouardi, Moulay Youssef Alaoui Lamrani, Hind El Fatimi, Bouchra Amara, Mounia Serraj, et al.

    Background: This study aimed to develop a nomogram based on the most relevant clinical, CT, and radiomic features comprising 11 key signatures (2 clinical, 2 CT-based, and 7 radiomic) for the non-invasive prediction of the EGFR mutation status and to support the timely initiation of tyrosine kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer (NSCLC) adenocarcinoma. Methods: Retrospective real-world data were collected from 521 patients with histologically confirmed NSCLC adenocarcinoma who underwent CT imaging and either surgical resection or pathological biopsy for EGFR mutation testing. Five Random Forest classification models were developed and trained on various datasets constructed by combining clinical, CT, and radiomic features extracted from CT image regions of interest (ROIs), with and without feature preselection. Results: The model trained exclusively on the most relevant clinical, CT, and radiomic features demonstrated superior predictive performance compared to the other models, with strong discrimination between EGFR-mutant and wild-type cases (AUC = 0.88; macro-average = 0.90; micro-average = 0.89; precision = 0.90; recall = 0.94; F1-score = 0.91; and accuracy = 0.87). Conclusions: A nomogram constructed using a Random Forest model trained solely on the most informative clinical, CT, and radiomic features outperformed alternative approaches in the non-invasive prediction of the EGFR mutation status, offering a promising decision-support tool for precision treatment planning in NSCLC.


  • Copyright protection of multiple CT images using Octonion Krawtchouk moments and grey Wolf optimizer

    by Mohamed Yamni, Achraf Daoui, Hicham Karmouni, Sarah Elmalih, Anass Ben-Fares, Mhamed Sayyouri, Hassan Qjidaa, Mustapha Maaroufi, Badreeddine Alami, Mohammed Ouazzani Jamil